retatrutide type 2 diabetes phase 2 weight loss 2024 ⚠️ BEWARE OF SOLD ONLINE! There are many "miracle" solutions spreading on social media, but not all are safe. Retatrutide is still undergoing clinical trials and NO FDA APPROVAL Retatrutide study sees significant weight

The prevalence of obesity is increasing, rates have tripled since 1963 from 5 % to now 19 % of US children affected in 2018

In major clinical trials, such as the landmark STEP 1 trial published in the New England Journal of Medicine , a once-weekly injection of semaglutide 2.4 mg resulted in an average body weight reduction of roughly 14.9% over 68 weeks

10 GLP-1 clinics in Branson are currently accepting new patients

Pubmed Central PMCID: 3594872)

Reduced appetite and altered eating patterns can potentially lead to inadequate intake of essential nutrients important for maintaining skin integrity and repair mechanisms